CollPlant Biotechnologies Ltd. (CLGN) is a Healthcare stock, with a market capitalization of $4.12M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
CollPlant Biotechnologies Ltd. operates in the Healthcare sector, Medical Equipment industry. The provided facts do not describe its specific products or how it generates revenue.
With gross margin -115% and operating margin -1770%, the business does not generate enough gross profit to cover operating costs.
Business quality (Unprofitable): Unprofitable (gross margin -115%, operating margin -1770%).
| Market Cap | $4.12M |
| EV / EBITDA | 0.1 |
| Price / Book | 0.68 |
| Price / Sales | 1.74 |
| FCF Yield | -229.2% |
| Revenue (TTM) | $2.37M |
| Net Margin | -484.6% |
| Return on Equity | -188.9% |
| Current Ratio | 2.53 |
| Revenue Growth (YoY) | 360.4% |
| EPS Growth (YoY) | -35.2% |
| FCF Growth (YoY) | -35.2% |
| Altman Z-Score | -18.52 (distress) |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| Sector | Healthcare |
| Industry | Medical Equipment |
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.